Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06769672

Dual-task Training Combined With tDCS on Cognitive-motor Performance and Brain Activity in Stroke Patients

The purpose of this study is to evaluate tDCS combined with cognitive-motor training on dual-task interference during dual-task walking, dual-task foot pedaling and the corresponding alterations of brain activity.

Recruiting

Interested in participating?

Request Info

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

In China, the prevalence of stroke increased by 106.0% (93.7-118.8) between 1990 and 2019, highlighting the persistent and substantial burden of this condition. Post-stroke recovery, particularly the ability to achieve community ambulation, plays a critical role in improving health-related quality of life. Effective community ambulation in daily life requires the ability to dual-task-namely, to perform concurrent tasks requiring attentional resources while maintaining walking function and balance. Emerging evidence suggests that stroke survivors face greater challenges in walking function and dual-task balance compared to their age-matched, able-bodied counterparts. For instance, when tasked with recalling a shopping list while walking, stroke patients exhibit a more pronounced decline in both walking speed and cognitive performance relative to control groups. Given the necessity for stroke survivors to reintegrate into the community, it is imperative to thoroughly investigate this phenomenon of cognitive-motor interference.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • a diagnosis of stroke, stroke onset of more than 6 months,
  • aged 50 or more,
  • capable of following verbal and visual instructions,
  • having a Montreal Cognitive Assessment score ≥ 22,
  • able to walk for 10 meters with/without a mobility aid,
  • community-dwelling, unilateral stroke

Exclusion criteria

  • neurological disorders, gait-precluding pain or comorbidity,
  • receiving any formal rehabilitation training,
  • contraindications to exercise (e.g., unstable angina),
  • contraindications to fNIRS, MRI, and tDCS (e.g., brain skin injury, pacemaker, metal implants in the brain),
  • history of seizure or epilepsy,
  • color blindness.
  • unable to walk with/without a mobility aid while responsing stimulus by the remote control

Treatment and study plan

active tDCS with dual-task training

Other

participants receive three 20-minute active tDCS treatment and three 60-minute COGMOTION dual-task exercise sessions per week for four consecutive weeks.

sham tDCS with dual-task training

Other

participants receive three 20-minute sham tDCS treatment and three 60-minute COGMOTION dual-task exercise sessions per week for four consecutive weeks.

Primary outcomes

  1. Dual-task gait speed

    Time frame: Through study completion, an average of 1 year

    Gait speed under dual-task condition will be recorded

  2. Dual-task cognitive performance

    Time frame: Through study completion, an average of 1 year

    Number of correct responses will be measured during dual-task conditions

Secondary outcomes

  1. Oxyhemoglobin concentration changes of the brain

    Time frame: Through study completion, an average of 1 year

    Oxyhemoglobin concentration changes will be measured using functional near infra-red spectroscopy during dual-task walking

  2. Dual-task gait performance 1

    Time frame: Through study completion, an average of 1 year

    Gait cadence will be measured during dual-task walking

  3. Dual-task gait performance 2

    Time frame: Through study completion, an average of 1 year

    Gait cycle duration will be measured during dual-task walking

  4. Dual-task gait performance 3

    Time frame: Through study completion, an average of 1 year

    Stride length will be measured during dual-task walking

  5. Dual-task cognitive performance 1

    Time frame: Through study completion, an average of 1 year

    Correct reaction time under dual-task walking will be recorded

  6. Blood oxygenation level changes of the brain

    Time frame: Through study completion, an average of 1 year

    Blood oxygenation level changes will be measured using Magnetic Resonance Imaging during dual-task foot pedaling

  7. Dual-task stride time

    Time frame: Through study completion, an average of 1 year

    cadence under dual-task foot pedaling will be recorded

  8. Dual-task cognitive performance 2

    Time frame: Through study completion, an average of 1 year

    Number of correct responses under dual-task foot pedaling will be recorded

  9. Dual-task gait performance 4

    Time frame: Through study completion, an average of 1 year

    Step time under dual-task walking will be recorded

Other outcomes

  1. Dual-task peak angular velocity

    Time frame: Through study completion, an average of 1 year

    Peak angular (dorsi-plantar flexion) velocity under dual-task foot pedaling will be recorded

  2. Dual-task cognitive performance 3

    Time frame: Through study completion, an average of 1 year

    Correct reaction time under dual-task foot pedaling will be recorded

  3. Single-task walking speed

    Time frame: Through study completion, an average of 1 year

    10-meter walking test will be used to assess single-task walking speed in meters per second

  4. Balance 1

    Time frame: Through study completion, an average of 1 year

    Mini Balance Evaluation Systems Test will be used to assess postural control, with total points from 0-28. Higher points indicate better performance.

  5. Balance 2

    Time frame: Through study completion, an average of 1 year

    Activities-specific Balance Confidence Scale will be used to assess confidence of functional balance performance, with total points from 0-100. Higher points indicate better performance.

  6. Cognitive performance

    Time frame: Through study completion, an average of 1 year

    Stroop color word test will be used to assess executive function

  7. Cognitive performance 1

    Time frame: before the initiation of training

    Montreal Cognitive Assessment will be used to assess global cognition, with total points from 0-30. Higher points indicate better performance.

  8. Cognitive performance 2

    Time frame: Through study completion, an average of 1 year

    Trail Making Test will be used to assess executive function

  9. Fall incidence

    Time frame: Through study completion, an average of 1 year

    Monthly telephone interviews for recording fall incidence

  10. dual-task walking performance at maximal speed

    Time frame: Through study completion, an average of 1 year

    Walking time under dual-task walking at maximal speed will be recorded

  11. dual-task cognitive performance at maximal speed

    Time frame: Through study completion, an average of 1 year

    Accuracy under dual-task walking at maximal speed will be recorded

Study contacts

Contact information is provided by the study sponsor or research team.

Prof. Marco PANG

CONTACT

[email protected]

+852 2766 7156

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Registry information

Official study title

The Effect of Dual-task Training Combined With tDCS on Cognitive-motor Interference and Related Brain Activity in Stroke Patients

Acronym: dual-task tDCS

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 10, 2025
Registry last updated
Feb 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.